DEPICT: Dynamic Evolution of Pulmonary Nodules and Influence Factors of Its Clinical Decision-making

Sponsor
GuiBin Qiao (Other)
Overall Status
Recruiting
CT.gov ID
NCT04857333
Collaborator
(none)
2,000
1
60
33.4

Study Details

Study Description

Brief Summary

The researchers are aimed to investigate the dynamic evolution of indeterminate pulmonary nodules by a long-term follow-up of patients with different characteristics. Influence factors of clinical decision-making that might contribute to overtreatment or delayed treatment will also be studied.

Condition or Disease Intervention/Treatment Phase

Detailed Description

This observatory study prospectively recruits patients with indeterminate pulmonary nodules identified in computed tomography (CT) scans from thoracic clinic. The radiological features and their chronological changes during follow-up period will be recorded in detail. Subgroup analyses will be performed based on the clinical and demographic characteristics of patients (including symptomatic information, comorbidities, family history, antibiotic usage, etc). Hospital Anxiety and Depression Scale (HADS) is collected from each patient at multiple time points to evaluate the patients' psychological status and its impact on clinical decision-making. The interaction analyses between individual characteristics (such as education level, occupation, disease cognitive level, etc) and Hospital Anxiety and Depression Scale will also be performed. The researchers aim to provide high-quality evidence for the formulation of a precise follow-up and management plan for patients with pulmonary nodules.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
2000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Dynamic Evolution of Pulmonary Nodules and Influence Factors of Its Clinical Decision-making: A Prospective Cohort Study
Actual Study Start Date :
Jan 1, 2021
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Dec 31, 2025

Arms and Interventions

Arm Intervention/Treatment
Pulmonary Nodule

Patients are recommended for using antibiotics, solely follow-up or surgical resection according to the current clinical guideline for management of indeterminate pulmonary nodule. No intervention is administered for this observatory study.

Diagnostic Test: CT scan
For patients with low-risk pulmonary nodules, follow-up CT scan is recommended

Drug: Antibiotics
For pulmonary nodules with features of infectious disease, antibiotics is recommended

Procedure: Surgical Resection
For persistent high-risk pulmonary nodules, surgical resection is recommended

Outcome Measures

Primary Outcome Measures

  1. Time to surgical resection [The date of first documented diagnosis of pulmonary nodule by CT scan to the date of surgical resection, up to 60 months]

    Time calculated from the date of identification of pulmonary nodule to the date of surgical resection

  2. Time to progression [The date of first documented diagnosis of pulmonary nodule by CT scan to the date of documented progression by CT scan, up to 60 months]

    Time calculated from the date of identification of pulmonary nodule to the date of progression of pulmonary nodule based on evaluation of CT imaging

Secondary Outcome Measures

  1. Proportion of malignancy [The date of first documented diagnosis of pulmonary nodule by CT scan to the date of surgical resection, up to 60 months]

    Proportion of malignant findings by pathological examination in all patients receiving surgical resection

  2. Change of Hospital Anxiety and Depression Scale-Anxiety (HADS-A) score [The date of enrollment in our cohort study when Hospital Anxiety and Depression Scale is measured to the date when primary endpoint( surgical resection) is reached, up to 60 months, with multiple measurements.]

    The differences of Hospital Anxiety and Depression Scale-Anxiety (HADS-A) scores of the same patients before and after surgical resection. This 7-item checklist is a part of the Hospital Anxiety and Depression Scale, which is used for assessment for the status of anxiety. The maximal score for HADS-A is 21. Scores of greater than or equal to 11 on either scale indicate a definitive case. Scores of 0-7 are defined to be normal, while scores of 8-10 are defined to be borderline abnormal (borderline case).

  3. Change of Hospital Anxiety and Depression Scale-Depression (HADS-D) score [The date of enrollment in our cohort study when Hospital Anxiety and Depression Scale is measured to the date when primary endpoint( surgical resection) is reached, up to 60 months, with multiple measurements.]

    The differences of Hospital Anxiety and Depression Scale-Depression (HADS-D) scores of the same patients before and after surgical resection. This 7-item checklist is a part of the Hospital Anxiety and Depression Scale, which is used for assessment for the status of depression. The maximal score for HADS-D is 21. Scores of greater than or equal to 11 on either scale indicate a definitive case. Scores of 0-7 are defined to be normal, while scores of 8-10 are defined to be borderline abnormal (borderline case).

Eligibility Criteria

Criteria

Ages Eligible for Study:
14 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Patients with pulmonary nodules ≤ 3cm

  2. Patients who provide electronic, written or oral consent to be enrolled in the follow-up cohort

Exclusion Criteria:
  1. Patients with a surgical history of pulmonary nodules;

  2. Patients who have obtained pathological diagnosis through surgery or non-surgical methods such as puncture;

  3. Patients with pulmonary nodules that are likely metastatic from other sites;

  4. Refuse to participate in this study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Guangdong Provincial People's Hospital Guangzhou Guangdong China 510080

Sponsors and Collaborators

  • GuiBin Qiao

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
GuiBin Qiao, Administrative Director, Department of Thoracic Surgery, Guangdong Provincial People's Hospital
ClinicalTrials.gov Identifier:
NCT04857333
Other Study ID Numbers:
  • KY-Q-2021-005-03
First Posted:
Apr 23, 2021
Last Update Posted:
Apr 23, 2021
Last Verified:
Apr 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by GuiBin Qiao, Administrative Director, Department of Thoracic Surgery, Guangdong Provincial People's Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 23, 2021